Long Daniel D.
Officer at SEPN
- Sold, on record
- $951k
- Dollars the filings state
- Form 4 sales
- 5
- Latest Sep 1, 2026
- Form 144 notices
- 3
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- SEPNSepterna, Inc.Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 144 notice SEPNNoticeNov 10, 2025 2025
Filed to sell 3,501 shares ($63k)
Long Daniel D., Officer
No 10b5-1 planFirst sale on recordFiling
- 2 Form 4 sale SEPNNo planNov 10, 2025 same day
Sold 3,501 shares at $18.06 ($63k)
Long Daniel D., SVP, Drug Discovery
No 10b5-1 planSold 3.6% of holdings ($1.7M position)92,911 shares leftFirst sale on recordFollows a Form 144Filing
- 3 Form 144 notice SEPNNoticeJun 22, 2026 +224 days
Filed to sell 25,000 shares ($904k)
Long Daniel D., Officer
10b5-1 planFiling
- 4 Form 4 sale SEPNRoutineJun 22, 2026 same day
Sold 15,000 shares at $35.51 ($533k)
Long Daniel D., SVP, Drug Discovery
10b5-1 planSold 13.5% of holdings ($4M position)96,412 shares leftFollows a Form 144Filing
- 5 Form 4 sale SEPNRoutineJul 1, 2026 +9 days
Sold 3,333 shares at $34.36 ($115k)
Long Daniel D., SVP, Drug Discovery
10b5-1 planSold 3.3% of holdings ($3.4M position)96,412 shares leftFollows a Form 144Filing
- 6 Form 4 sale SEPNRoutineAug 3, 2026 +33 days
Sold 3,334 shares at $34.47 ($115k)
Long Daniel D., SVP, Drug Discovery
10b5-1 planSold 3.3% of holdings ($3.4M position)96,412 shares left1x usual sizeFollows a Form 144Filing
- 7 Form 4 sale SEPNRoutineSep 1, 2026 +29 days
Sold 3,333 shares at $37.83 ($126k)
Long Daniel D., SVP, Drug Discovery
10b5-1 planSold 3.3% of holdings ($3.8M position)96,412 shares left1x usual sizeFollows a Form 144Filing
- 8 Form 144 notice SEPNNoticeOct 1, 2026 +30 days
Filed to sell 10,001 shares ($391k)
Long Daniel D., Officer
10b5-1 plan3x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (8)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | Oct 1, 2026 | SEPN | Officer | Form 144 notice | 10,001 | $391k | Notice | SEC | |
| Sep 1, 2026 | Sep 3, 2026 | SEPN | SVP, Drug Discovery | Form 4 sale | 3,333 | $126k | 3.3% | Routine | SEC |
| Aug 3, 2026 | Aug 5, 2026 | SEPN | SVP, Drug Discovery | Form 4 sale | 3,334 | $115k | 3.3% | Routine | SEC |
| Jul 1, 2026 | Jul 2, 2026 | SEPN | SVP, Drug Discovery | Form 4 sale | 3,333 | $115k | 3.3% | Routine | SEC |
| Jun 22, 2026 | Jun 24, 2026 | SEPN | SVP, Drug Discovery | Form 4 sale | 15,000 | $533k | 13.5% | Routine | SEC |
| Jun 22, 2026 | Jun 22, 2026 | SEPN | Officer | Form 144 notice | 25,000 | $904k | Notice | SEC | |
| Nov 10, 2025 | Nov 13, 2025 | SEPN | SVP, Drug Discovery | Form 4 sale | 3,501 | $63k | 3.6% | No plan | SEC |
| Nov 10, 2025 | Nov 10, 2025 | SEPN | Officer | Form 144 notice | 3,501 | $63k | Notice | SEC |